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ABSTRACT 
Chronic hyperglycemia induces non-enzymatic protein glycation, which plays an important 
role in the development of diabetic complications. Immense efforts have been made to deter-
mine effective antiglycation compounds from natural products. Pomelo has shown beneficial 
effects for human health. The objective of this study was to determine the antiglycation effect 
of pomelo extract against fructose-mediated protein oxidation and glycation. Our results 
showed that the pomelo extract (0.25 - 2.00 mg/mL) significantly inhibited the overall for-
mation of advanced glycation end products (AGEs) in a concentration-dependent manner. The 
pomelo extract markedly decreased the level of fructosamine, which is directly associated 
with reduction in formation of AGEs and N-(carboxymethyl)lysine (CML). In addition, the 
pomelo extract inhibited protein oxidation through its ability to prevent the loss of thiol 
groups and reduced protein carbonyl formation. We characterized the active components in 
the pomelo extract by using high-performance liquid chromatography (HPLC), which showed 
that the pomelo extract contained naringin (11.90  0.21 mg/g dried extract), hesperidin 
(12.04  0.12 mg/g dried extract), neohesperidin (25.4  0.12 mg/g dried extract), and 
naringenin (9.20  0.19 mg/g dried extract). Our findings could provide a new insight into the 
antiglycation properties of the extract of the naturally occurring fruit pomelo for preventing 
AGE-mediated diabetic complications.  
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INTRODUCTION 
Glycation is a non-enzymatic reaction 
that occurs between a carbonyl group of a 
sugar and an amino group of an amino acid, 
which leads to formation of reversible 
structure or a Schiff’s base (Brownlee, 
1995). Subsequently, the initial Schiff’s ba-
se undergoes rearrangements to from Ama-
dori products, which induce further oxida-
tion to generate dicarbonyl compounds to 
form cross-linking fluorescent (e.g. pento-
sidine) and non-fluorescent adducts (e.g. 
N-(carboxymethyl)lysine [CML]) called as 
advanced glycation end products (AGEs). 
Recent studies indicate that the formation 
and accumulation of AGEs in the tissues 
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have been implicated in the progression of 
diabetic complications such as retinopathy, 
nephropathy, and neuropathy (Ahmed, 
2005; Schmidt and Stern, 2000). Nowa-
days, antiglycation agents have attracted a 
lot of attention for alleviating diabetic com-
plications (Wu et al., 2011). A representa-
tive antiglycation drug is aminoguanidine 
(AG), which acts by blocking cross-link 
formation by interacting with post-Amadori 
reactive intermediates to prevent the for-
mation of AGEs from dicarbonyl precursors 
(Thornalley, 2003). However, previous 
studies have shown that AG has toxic ef-
fects in diabetes patients, such as flu-like 
symptoms, gastrointestinal problems and 
anemia (Bolton et al., 2004; Thornalley, 
2003). Therefore, attention has also been 
focused on the antiglycation properties of 
phytochemicals present in fruits and vege-
tables (Adisakwattana et al., 2010; Dear-
love et al., 2008; Wu et al., 2009). Natural 
AGE inhibitors may have promising thera-
peutic potential in delaying the onset and 
preventing aging and diabetic complica-
tions. 
Pomelo (Citrus grandis L.), which be-
longs to the family Rutaceae, is one of the 
most widely cultivated crops in Southeast 
Asia. In the past, the pulp of pomelo has 
been used as an appetizer, antitoxic, cardiac 
stimulant, and stomach tonic (Arias and 
Ramón-Laca, 2005). The major flavonoids 
of pomelo are neohesperidin, hesperidin, 
naringenin, and naringin, which are present 
in high amounts in fruit juice (Kanes et al., 
1993; Kawaii et al., 1999; Xu et al., 2008). 
Recently, a number of studies on pomelo 
extract have reported the favorable antioxi-
dant properties through free radical-
scavenging effects in vitro (Chung, 2000; 
Jayaprakasha et al., 2008; Lim et al., 2006). 
In addition, the pomelo extract reduces the 
reactive oxygen species in hydrogen perox-
ide (H2O2)-treated HepG2 cells (Lim et al., 
2006). However, to date, no study has re-
ported the antiglycation activity of pomelo. 
In the present study, we clarified the effect 
of the pomelo extract against fructose-
mediated non-enzymatic glycation. In addi-
tion, we examined the inhibitory effect of 
pomelo extract on oxidation-dependent 
damages induced by fructose to bovine se-
rum albumin (BSA). This study will under-
line the importance of pomelo extract in 
prevention of hyperglycemia-mediated pro-
tein modification. 
 
MATERIALS AND METHODS 
Chemicals 
Naringin, hesperidin, neohesperidin, 
naringenin, neohesperidin dihydrochalcone, 
hesperitin, BSA (fraction V), AG hydro-
chloride, 5,5′-dithiobis-(2-nitrobenzoic ac-
id) (DTNB), guanidine hydrochloride, ni-
troblue-tetrazolium (NBT), and L-cysteine 
were purchased from Sigma–Aldrich Co. 
(St. Louis, MO, USA). Fructose and 2,4-
dinitrophenylhydrazine (DNPH) were pur-
chased from Ajax Finechem (Taren Point, 
Australia). Trichloroacetic acid (TCA) was 
purchased from Merck (Darmstadt, Germa-
ny). OxiSelect™ CML ELISA kit was ob-
tained from Cell Biolabs (San Diego, CA, 
USA). All other chemicals and solvents 
used in this study were of analytical grade. 
 
Preparation of extract  
Pomelo (Kao Yai) was obtained from 
Nakhon Phatom province and harvested at 
mature stage (Figure 1). The pulp of pome-
lo was collected by manual peeling from 
the peel and then homogenized using a 
commercial blender. The pulp was lyophi-
lized and exhaustively extracted in a 2-step 
aqueous methanol process at 4 °C for 6 
consecutive days. The supernatant was 
evaporated in a rotary evaporator at 60 °C 
and stored in the dark under a vacuum 
dessiccator at room temperature. Thereaf-
ter, the dried extract was purified to discard 
sugars and organic acids using a Sep-Pak 
C18 Cartridge (Li et al., 2006). 
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Figure 1: The fruit (left) and pulp (right) of pomelo “Kao Yai” 
 
 
In vitro glycation of BSA 
The formation of glycated BSA was ex-
amined according to a previously described 
method (Adisakwattana et al., 2012). Brief-
ly, BSA (10 mg/mL) was incubated with 
1.1 M fructose in 0.1 M phosphate buff-
ered-saline, pH 7.4, containing 0.02 % so-
dium azide in the dark at 37 °C for 7, 14, 
21, and 28 days. Before incubation, the 
pomelo extract was added to the mixtures. 
We used 10 % dimethylsulfoxide (DMSO) 
as a solvent for this study. The amount of 
glycated BSA formed was measured on the 
basis of the fluorescent intensity at an exci-
tation wavelength of 355 nm and an emis-
sion wavelength of 460 nm. 
 
Determination of fructosamine 
The concentration of fructosamine, the 
Amadori product, was measured by using 
the NBT assay (Adisakwattana et al., 2012). 
Glycated BSA (10 L) was incubated at 
37 °C with 200 L of 2.5 mM NBT in 0.1 
M carbonate buffer, pH 10.4. The absorb-
ance was recorded at 590 nm at 2 time in-
tervals, the first reading was at 10 min and 
the second was at 15 min. The concentra-
tion of fructosamine was calculated using 
different absorption values at the 10 and 15 
min time points, and these values were 
compared to that of 1-deoxy-1-morpholino-
fructose (1-DMF) as the standard. 
 
Determination of carbonyl content  
For the assessment of the extent of pro-
tein oxidation, we measured the protein 
carbonyl content (Uchida et al., 1998). To 
measure the protein carbonyl content, gly-
cated BSA (100 L) was reacted with 
400 L of 10 mM DNPH at room tempera-
ture for 60 min. After incubation, 20 % 
TCA (500 L) was added to each solution 
and kept in ice for 5 min. After centrifuga-
tion at 10,000 rpm for 10 min at 4 °C, the 
supernatant was discarded and the pellets 
was resuspended in 500 L of 10 % TCA 
and then incubated on ice for 5 min. After 
incubation, the solution was centrifuged at 
10,000 rpm for 10 min at 4 °C. The super-
natant was discarded and the pellets were 
resuspended in 500 L of ethanol/ethyl ace-
tate (1/1) mixture and mixed thoroughly 
using a vortex mixer. After mixing, the so-
lution was centrifuged at 10,000 rpm for 10 
min at 4 °C. After discarding the superna-
tant, the process of resuspending the pellets 
and centrifugation was repeated twice. 
Then, 250 L of 6 M guanidine hydrochlo-
ride was added to the solution and the ab-
sorbance was measured at 370 nm. The 
concentration of the protein carbonyl group 
was calculated using the extinction coeffi-
cient ( = 22,000 M-1cm-1). The results were 
expressed as nmol carbonyl/mg protein. 
 
Determination of thiol concentration  
Glycated BSA (70 L) was incubated 
with 2.5 mM DNTB (130 L) in 0.1 M 
phate-buffered saline (PBS), pH 7.4, at 
room temperature for 15 min. After incuba-
tion, the absorbance was recorded at 
410 nm. The concentration of free thiol was 
calculated by using the standard curve for 
L-cysteine (Sedlak and Lindsay, 1968). The 
results were expressed as nmol/mg protein. 
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Determination of CML concentration 
The concentration of CML, a major 
AGE, was determined by using an enzyme 
linked immunosorbent assay (ELISA) kit. 
The concentration of CML was calculated 
by using the standard curve of CML-BSA 
from the assay kit. 
 
Quantification of flavonoid constituents 
The flavonoid contents were determined 
using a slight modification of a previously 
described method (Zhang et al., 2011). The 
flavonoid content in the pomelo extract was 
determined using high-performance liquid 
chromatography (HPLC) (Shimadzu, Kyo-
to, Japan) consisting of a binary pump 
(model LC-10A), an auto-injector (model 
SIL-10A), and a UV detector (model SPD-
10A). The flavonoid separation was per-
formed using reversed-phase Vertic SepTM 
UPS C-18 column (4.6 × 250 mm, 5 m, 
Vertical Chromatography). The mobile 
phase consisted of  
(A): water/acetic acid (99:1, v/v) and  
(B): acetone nitrile/acetic acid (99:1, v/v). 
The gradient was as follows:  
 0 min, 5% B;  5 min, 8% B;  
 7 min, 12% B;  12 min, 18% B;  
 17 min, 22% B;  22 min, 25% B;  
 27 min, 35% B;  37 min, 53% B;  
 38 min, 53% B;  40 min, 55% B;  
 42 min, 60% B;  57 min, 80% B;  
 60 min, 85% B; and 65 min, 85% B.  
The flow rate was 1.2 ml/min. The 
chromatograms were captured at 280 nm. 
Flavonoids were quantified by using nar-
ingin, hesperidin, neohesperidin, and 
naringenin as standards. Chromatographic 
identification and confirmation of flavonoid 
compounds was performed by comparing 
their retention times with those of authentic 
standards and spiking the samples with 
standard solutions. Eight-point calibration 
curves (0–250 g/mL) were used for each 
standard. 
 
Statistical analysis 
Data were expressed as mean  standard 
error of mean (SEM) for all experimental 
measurements based on triplicate results (n 
= 3). Significant differences were deter-
mined using one-way analysis of variance 
(ANOVA) followed by a post-hoc test with 
Tukey’s range test. Significant differences 
were considered at P < 0.05. 
 
RESULTS  
The effect of pomelo extract on total  
fluorescence intensity of glycated BSA  
in terms of total AGEs  
The formation of AGEs was monitored 
weekly by measuring the fluorescence in-
tensity. The fluorescence intensity marked-
ly increased after incubation with BSA and 
fructose (Figure 2). The pomelo extract 
(0.25 - 2.00 mg/ml) significantly reduced 
the formation of AGEs in a concentration-
dependent manner. AG (0.50 mg/mL) 
showed an effect similar to that of the pom-
elo extract (0.50 mg/mL), in that AG sup-
pressed the formation of AGEs. The per-
centage inhibition of formation of AGEs by 
the pomelo extract (0.25–2.00 mg/mL) 
markedly increased in a concentration-
dependent manner throughout the incuba-
tion period of 28 days (Table 1). At the 
same concentration of 0.50 mg/mL, the 
percentage inhibition by the pomelo extract 
was the same as that by AG at day 28. 
 
The effect of pomelo extract on formation 
of Amadori products 
Fructose-mediated glycation of BSA 
significantly increased the fructosamine 
level after 7 days of study (Table 2). More-
over, the fructosamine level markedly in-
creased throughout the 28 days of experi-
ment. The addition of pomelo extract and 
AG significantly suppressed the generation 
of fructosamine. At the end of the study pe-
riod, the pomelo extract at concentration of 
0.25, 0.50, 1.00, and 2.00 mg/mL reduced 
the level of fructosamine approximately by 
3.7 %, 9.9 %, 17.5 %, and 30.0 %, respec-
tively, whereas AG (0.50 mg/mL) de-
creased the level of fructosamine by 
12.5 %. 
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Figure 2: Effects of pomelo extract on fluorescent modification derived from formation of advanced 
glycation end products (AGEs) in bovine serum albumin (BSA) incubated with fructose. Each value 
represents the mean  standard error (SE, n = 3). *P < 0.05 compared to BSA alone at the same 
week, # P < 0.05 compared to BSA+F (Fructose) at the same week 
 
 
Table 1: The percentage inhibition of pomelo extract on the formation of fluorescence AGE at day 7, 
14, 21, and 28 
Samples  
% Inhibition 
Day 7 Day 14 Day 21 Day 28 
BSA+F+PE 0.25 mg/ml 78.37  0.74 67.32  4.12 59.05  2.20 49.97  0.96 
BSA+F+PE 0.50 mg/ml 87.49  1.19 82.32  1.37 74.69  1.64 71.53  0.52 
BSA+F+PE 1.00 mg/ml 91.04  0.03 88.85  0.95 87.01  0.66 86.31  0.48 
BSA+F+PE 2.00 mg/ml 94.68  0.73 92.06  0.73 91.75  0.42 90.68  0.42 
BSA+F+AG 0.50 mg/ml 85.23  1.89 86.06  0.56 81.81 4.54 73.62  0.90 
Data are expressed as mean ± SEM, n =3 (F = fructose, PE = pomelo extract). 
 
Table 2: The effect of pomelo extract on the level of fructosamine at day 7, 14, 21, and 28 
Samples 
Fructosamine (mM) 
Day 7 Day 14 Day 21 Day 28 
BSA 1.03  0.02 1.12 0.06 1.230.20 1.490.08 
BSA + F 1.77  0.07* 2.17 0.06* 2.490.16* 2.730.33* 
BSA+F+PE 0.25 mg/ml 1.47  0.21 1.80  0.04# 2.31 0.01 2.630.02 
BSA+F+PE 0.50 mg/ml 1.39  0.06# 1.70  0.03# 2.07  0.12# 2.460.02 
BSA+F+PE 1.00 mg/ml 1.28  0.11# 1.44  0.03# 1.88  0.06# 2.250.01# 
BSA+F+PE 2.00 mg/ml 1.13  0.10# 1.20  0.01# 1.57  0.21# 2.030.03# 
BSA+F+AG 0.50 mg/ml 1.47  0.21# 1.88  0.16# 1.88  0.06# 2.390.01# 
Data are expressed as mean ± SEM, n =3 (F = fructose, PE = pomelo extract). *P < 0.05 compared to BSA. #P < 0.05 com-
pared to BSA+F.  
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The effect of pomelo extract on glycation-
induced oxidative modification of BSA 
The determination of carbonyl content 
and thiol groups was used to assess the pro-
tein oxidation that occurred during the pro-
cess of glycation. The carbonyl content of 
glycated BSA significantly increased com-
pared to that with BSA alone at day 28 (Ta-
ble 3). Furthermore, the pomelo extract sig-
nificantly decreased the protein carbonyl 
content at concentration of 1 and 2 mg/mL. 
The percentage reduction of carbonyl con-
tent by pomelo extract at concentration of 
1.00 and 2.00 mg/mL was 9.2 % and 
28.5 %, respectively, whereas that by AG 
(0.50 mg/mL) was 11.1 %. The effects of 
pomelo extract on the oxidation of protein 
thiols are shown in Table 3. At day 28, 
compared to BSA alone, BSA incubated 
with fructose significantly decreased the 
level of thiol group. A significant increase 
(20.0 %) was observed in the level of thiol 
group in fructose-induced glycated BSA 
plus pomelo extract (2.00 mg/mL).  
 
The effect of pomelo extract on CML for-
mation  
CML has been used as a biomarker for 
the formation of the non-fluorescent AGEs 
on 28 day. The pomelo extract at a concen-
tration of 0.50 mg/mL significantly inhibit-
ed the formation of CML by 90.0 % in 
BSA/fructose (Figure 3). In addition, AG 
(0.50 mg/mL) decreased the level of CML 
by approximately 61.0 %. 
HPLC chromatogram  
The flavonoid composition of pomelo 
extract was analyzed using HPLC (Figure 
4). Comparison of the RT and UV spectra 
of compound 1, 2, 3, and 5 with those of the 
standard indicated that these compounds 
were naringin, hesperidin, neohesperidin, 
and naringenin, respectively. The results re-
vealed that neohesperidin (25.40  
0.12 mg/g dried extract) was a major com-
pound in the pomelo extract followed by 
naringin (11.90  0.21 mg/g dried extract), 
hesperidin (12.04  0.12 mg/g dried ex-
tract), and naringenin (9.20  0.19 mg/g 
dried extract). 
 
Figure 3: Effects of pomelo extract on the level 
of Nε-(carboxymethyl) lysine (CML) in bovine 
serum albumin (BSA) incubated with fructose 
after 28 days. Each value represents the mean 
± standard error of mean (SEM, n = 3). 
*P < 0.05 compared to BSA+F (Fructose) 
 
 
Table 3: The effect of pomelo extract on the formation of carbonyl content and the level of thiol group 
at day 28 
Samples Carbonyl content (nmol carbonyl/mg protein)
Thiol group 
(nmol /mg protein) 
BSA 1.00  0.01 2.72  0.09 
BSA+F 2.63  0.32* 1.29  0.17* 
BSA+F+PE 0.25 mg/ml 2.85  0.03 0.76  0.36 
BSA+F+PE 0.50 mg/ml 2.73  0.04 0.81  0.13 
BSA+F+PE 1.00 mg/ml 2.39  0.06# 1.16  0.15 
BSA+F+PE 2.00 mg/ml 1.88  0.04# 1.55  0.28# 
BSA+F+AG 0.50 mg/ml 2.33  0.35 1.06  0.60 
Data are expressed as mean ± SEM, n =3 (F = fructose, PE = pomelo extract).  
*P < 0.05 compared to BSA. #P < 0.05 compared to BSA+F.  
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(A) 
(B)
 
Figure 4: (A) High-performance liquid chromatography (HPLC) chromatograms at 280 nm of standard 
compounds at a concentration of 250 g/mL and (B) the pomelo extract (2 mg/mL). 
 
 
DISCUSSION 
In this study, we examined the anti-
glycation effect of pomelo extract against 
fructose-mediated non-enzymatic glycation 
and oxidation-dependent damage to BSA. 
We determined the effects of pomelo ex-
tract during the early stage (Amadori prod-
ucts), middle stage (protein oxidation), and 
last stage (the cross-linking compound) of 
AGE formation (Brownlee, 1995; Wu et al., 
2011). Reducing sugars are important mod-
ulators of non-enzymatic glycation that 
eventually results in irreversible formation 
of AGEs. Fructose, like other reducing sug-
ars, can react with proteins through non-
enzymatic glycation, which may account 
for accelerating aging and chronic diabetic 
complications (Suarez et al., 1989; Yeboah 
et al., 1999). Fructose spontaneously reacts 
EXCLI Journal 2013;12:491-502 – ISSN 1611-2156 
Received: December 03, 2012, accepted: May 07, 2013, published: June 10, 2013 
 
 
498 
with the amino group of BSA forming 
Schiff bases that spontaneously rearrange to 
Amadori products, also called fructosa-
mine. Fructosamine is clinically used as an 
indicator for short-term control of blood 
glucose level in diabetic patients (Ardestani 
and Yazdanparast, 2007). Reduction in 
fructosamine levels is a therapeutic strategy 
to delay the progression of vascular com-
plications (Shield et al., 1994). Further-
more, the formation and accumulation of 
AGEs is enhanced by chronic hyperglyce-
mia (Fu et al., 1994). CML is one of the 
most abundant AGEs that is formed be-
tween a reactive carbonyl intermediate and 
an amino acid residue during the formation 
of a Schiff base (Reddy et al., 1995). In ad-
dition, many studies have shown that CML 
is closely related to the pathogenesis of the 
diabetes complications, retinopathy, and 
nephropathy (Monnier et al., 2005). 
Besides the formation of AGEs, reactive 
carbonyl intermediaries and protein car-
bonyl derivatives also cause protein modifi-
cations that are particularly prone to oxida-
tive reactions with an amino acid such as 
cysteine. This amino acid is an important 
component of protein that maintains the 
protein structure, enzymatic activity, and 
antioxidant activity. However, it can be de-
stroyed by the oxidation, which results in 
the release of free thiol groups (Dalle-
Donne et al., 2003). The oxidation of thiol 
groups results in conformational changes in 
protein structure, which create disulfide 
bonds, and generate high levels of free rad-
icals (Murphy and Kehrer, 1989). Thus, the 
increased levels of oxidized thiol groups are 
reflective of high oxidative stress, protein 
oxidative damage, and formation of AGEs. 
Therefore, major molecular modifications 
in the protein structure can be determined 
by measuring the level of protein carbonyl 
groups and the loss of protein thiol groups, 
which is the direct reflection of the high 
amounts of free radical generation. 
Pomelo, a native citrus fruit to South-
east Asia and one of the largest Citrus spe-
cies, is widely cultivated and utilized in 
Thailand. In addition, citrus flavonoids 
have been identified in the pulp of pomelo, 
such as naringin, narirutin, neohesperidin, 
and kaempferol (Abeysinghe et al., 2007). 
The flavonoids identified in our study are 
consistent with those reported previously 
(Kim et al., 2009; Zhang et al., 2011). A 
comprehensive previous study related to 
naturally occurring polyphenols and flavo-
noids showed that these agents could re-
duce the formation of fructosamine, which 
may be related with their antiglycoxidative 
properties (Wu et al., 2011). Previous stud-
ies indicate that natural flavonoids may 
play a role in the prevention of diabetic 
complications because flavonoids are capa-
ble of affecting multiple mechanisms in the 
inhibition of glycation. Sugar-mediated 
non-enzymatic protein glycation and oxida-
tion can be inhibited effectively when fla-
vonoids are added during the glycation pro-
cess (Wu and Yen, 2005). Matsuda et al. 
(2003) suggest that the structural require-
ments of flavonoids for inhibition of protein 
non-enzymatic glycation include hydroxyl 
groups at the 3′-, 4′-, 5-, and 7-positions, 
which increases the inhibitory activities. In 
addition to the structure-activity relation-
ships, flavones are more stronger than fla-
vonols, flavanones, and isoflavones 
(Matsuda et al., 2003). These findings are 
in agreement with another study, which 
shows that flavonoids suppress the total 
fluorescence AGEs in the order flavone > 
flavonol > flavanol > flavanone (Wu and 
Yen, 2005). A recent study in type 1 diabe-
tes patients showed that daflon 500, which 
is made up of the flavonoids diosmin 
(90 %) and hesperidin (10 %), decreases the 
level of hemoglobin A1c (HbA1C) (an 
Amadori product) accompanied by an in-
crease in glutathione peroxidase levels 
(Manuel y Keenoy et al.,1999). Our find-
ings indicate that pomelo extract reduces 
the level of fructosamine and the formation 
of CML and decreases the formation of 
AGEs. Accordingly, the inhibitory activity 
of pomelo on the formation of AGEs and 
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protein oxidation might be associated with 
its flavonoid content 
A number of recent studies indicate that 
trapping free radicals and inhibiting the 
formation of reactive carbonyl groups using 
antioxidant compound is one of the strate-
gies for inhibition of protein glycation. Pre-
vious studies have documented the antioxi-
dant activity of pomelo through its ability to 
inhibit the formation of free radicals gener-
ated by 1,1-diphenyl-2-picrylhydrazyl radi-
cal and to inhibit the oxidation of 2,2′-
azino-bis(3-ethylbenzothiazoline-6-sulpho-
nic acid) (ABTS+) (Jayaprakasha et al., 
2008; Lim et al., 2006). Moreover, the oxy-
gen radical absorbance capacity (ORAC) 
assay showed that the pomelo extract de-
creases peroxyl radicals (Jayaprakasha et 
al., 2008). The pomelo extract exhibits a 
high ability to reduce Fe3+ to Fe2+, which 
suggests its ability to suppress the progres-
sion of Fenton reaction and thus impeding 
the formation of a highly reactive hydroxyl 
radical (Pichaiyongvongdeeand and Haru-
enkit, 2009). Flavonoids in the pomelo ex-
tract have shown antioxidant activity, 
which is directly related to their ability to 
inhibit free radical formation and lipid pe-
roxidation. For example, hesperidin and 
neohesperidin dihydrochalcone effectively 
inhibit formation of superoxide and oxygen 
species (Suarez et al., 1998). In fact, flavo-
noids can trap reactive oxygen species and 
free radicals in various ways. One way is 
the direct scavenging of free radicals be-
cause of the phenolic hydroxyl groups in 
their structure, which readily donate elec-
trons to the unstable free radical and thus 
the free radical becomes more stable and 
less-reactive (Nijveldt et al., 2001). Previ-
ous studies, which support the proposed 
mechanisms of antiglycation by flavonoids 
mainly attribute this effect to the potent an-
tioxidant activities of the flavonoids (Wu 
and Yen, 2005). The scientists have re-
vealed that flavonoids show strong abilities 
to scavenge free radicals formed during 
glycation and prevent the self-oxidation of 
reducing sugars (Peng et al., 2011). Accord-
ing to these evidences, our findings suggest 
that the inhibitory effects of flavonoids in 
the pomelo extract on the AGE formation 
and protein oxidation are remarkably relat-
ed to their scavenging abilities of free radi-
cals formed during the glycation process. 
However, the antioxidant activity of flavo-
noids in the pomelo extract might not be the 
only reason for the antiglycation effect. The 
recent mechanisms underlying antiglycation 
include breaking the cross-linking struc-
tures in the formed AGEs, blocking the 
carbonyl or dicarbonyl groups in reducing 
sugars, Schiff bases, and inhibiting the for-
mation of late-stage Amadori products 
(Peng et al., 2011; Wu et al., 2011). Further 
comprehensive studies of flavonoids are 
required to evaluate the antiglycation 
mechanisms described above. 
 
CONCLUSIONS 
Our study describes the antiglycation 
effect of pomelo extract in the 
BSA/fructose system. Our findings showed 
marked inhibition of the formation of AG-
Es, fructosamine, and CML. The pomelo 
extract decreased the protein carbonyl con-
tent and prevented the loss of protein thiol 
in BSA. The pomelo extract has potential to 
be an antiglycation agent and offers re-
markable prospects for prevention of path-
ogenesis in conditions associated with dia-
betic complications and aging. 
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